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Defying global leaders in antiretroviral
drug research in her own back yard,
national health minister Dr Manto
Tshabalala-Msimang repeated her
conviction that micronutrients were a
viable alternative for mitigating the
rigours of AIDS – this time at South
Africa’s second national HIV/AIDS
conference.  
Addressing a press conference at the
start of the Durban event held from 7 -
10 June 2005,  Tshabalala-Msimang lived
up to expectations by unapologetically
reiterating her renegade views.
She also rebuked conference
chairperson, Professor Lynn Morris, for
asking whether her department would
be giving an update of the
government’s comprehensive national
HIV/AIDS plan, questioned long-term
free condom provision and linked
sexual abstinence and faithfulness to
President Mbeki’s moral regeneration
campaign.
After equating a therapeutic HIV
vaccine with traditional medicine,
Tshabalala-Msimang told the opening
plenary session of 3 900 scientists,
doctors, social workers and journalists
that an alternative approach to health
should be regarded as ‘an attempt to
restore our dignity as Africans through
traditional medicine’.  South Africans
needed ‘to have options’.  She said she
was weary of hearing people talk of
nutrition and ARVs when it should be a
question of ‘either or’.
Eat well – be well
She had seen people living with AIDS
brought into clinics in wheelbarrows
before being put on nutrition, ‘and the
next time I see them they are walking
and are well’.
In an apparent reference to the
erection of a stand at the conference by
German AIDS denialist and vitamin
salesman Matthias Rath (whom the
Treatment Action Campaign is suing for
defamation), the health minister added,
‘we’re not prepared to exclude any
international participation from this
conference – we can only learn from
what other countries are doing’.
The organisers, amid some initial
concern, allowed the Rath Foundation
to erect a stand in the exhibition hall,
reminding them of the general provision
not to cause any public disturbance or
disruption through their actions.
Besides an incident when some
HIV/AIDS activists briefly pelted them
with oranges the denialists were
handing out, their presence was largely
ignored.
Tshabalala-Msimang defiantly asked
the plenary session after her
government received some stinging
broadsides from former World Bank
Director, Dr Mamphela Ramphele:
‘What is this all about proof and tests –
nobody understands HIV and AIDS’.
Audience boos Manto
Ramphele had just delivered a powerful
and moving inaugural Nkosi Johnson
Memorial Lecture and the huge packed
amphitheatre hall audience seemed to
be in no mood for political rhetoric,
drowning out parts of Tshabalala-
Msimang’s subsequent address with
boos, especially whenever she
mentioned garlic. 
At the press briefing Tshabalala-
Msimang said she hoped the conference
would focus on ‘all the other diseases as
well – many people are dying of other
diseases also. It’s absolutely critical that
we take the totality of the disease
burden and say how we respond, so
nobody is excluded.’
She said osteoporosis, diabetes and
cardiovascular diseases were among the
top killers that she would have to
account for at the World Health
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Professor Lynn Morris, Chairperson of this
year’s national HIV/AIDS conference held in
Durban.
National health minister, Dr Manto
Tshabalala-Msimang at the Durban AIDS
conference.
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With just 10% of South Africans needing
antiretroviral (ARV) drugs actually on
treatment, scaling up South Africa’s
ARV rollout is an urgent priority or it
will take ‘years and years’ to impact on
the ever-burgeoning demand.
This was the sober warning from 
Dr Francois Venter, Clinical Director of
the Reproductive Health and HIV
Research Unit at Witwatersrand
University, in delivering a critical
appraisal of the State’s ARV programme
at the second national AIDS conference
in Durban last month.
Echoeing the Treatment Action
Campaign’s call for treating 200 000
adults and children by next year, Venter
said that with about 500 000 (of the five
million HIV-positive South Africans)
needing ARVs, ‘the initial thinking is to
try and get just half of these on ARV’.
It was worrying that recently the
numbers of patients going onto ARVs
nationally had actually declined slightly.
‘We have to get the numbers up as soon
as possible. Instead of 20 per month
coming onto treatment at a particular
facility, we need 400,’ he added.
ART ROLLOUT – THE CLOCK TICKS EVER LOUDER
Organization’s review of its Millennium
Development Goals this September.
The Durban conference was a chance
to respond on the AIDS front.
In the absence of a cure for AIDS, her
government was determined to back
strategies for sexual abstinence and
prevention. 
Even in New York, where she had
recently attended an international
health symposium, people were
astonished at ‘how many resources in
South Africa were being put into
fighting HIV/AIDS but are not being
harnessed’.
She said her department was not
‘chasing numbers (ARV recipients)’, but
rather seeking quality of care.  ‘When I
meet with my MECs all I ask is about
the quality of the service,’ she added.
Government was on target with an
AIDS-related treatment facility in every
province by the end of the year and
could ‘hold its head high’ on what it
had done about HIV/AIDS.
Morris rebuke
The minister’s sharp rebuke of
Professor Morris came while she was
fielding press questions, some of which
tackled her controversial views. 
She said of Morris’s request for
information about where the
government stood with its
comprehensive HIV/AIDS plan, ‘I
challenge you to answer your own
question,’ adding that Morris ‘should be
in a position to do so’ because she was
employed by her own Health
Department.
When Tshabalala’s Director-General,
Thami Mseleku, tried to calm matters
down by saying he thought Morris was
asking a logistical question, the minister
retorted ‘no, that is not what I heard her
say!’.  Interviewed later, Morris
expressed shock and bewilderment.
‘I need to slot her department in to
the presentation schedule of the
conference – that’s what I was after,’ she
told Izindaba.
No clear answers for SAMJ
Izindaba asked the minister whether she
could provide a ‘straight yes or no
answer, followed by her reasons, as to
whether she believed the benefits of
ARVs outweighed the costs.  Her
response came only after an
intervention by Mseleku (who said
science had no clear answer) and a
deferral to Medical Research Council
President-Elect, Professor Anthony
Mbewu.  Mbewu said it was ‘a tragedy’
that in spite of hundreds of clinical ARV
trials by multinational companies using
South Africans over the past 15 years,
‘we don’t have the data on the side-
effects and long-term prognosis (of
ARVs)’.
‘If you were to say what are the
benefits of ARVs per se, I’d say ask the
clinicians – but research is still going on
in terms of the benefit in say, 5 - 20
years,’ he added.  South Africa was
learning from the international context,
with Brazil already facing the
difficulties of ‘Regimen 2’, he said.
‘The benefits have still to be fully
quantified, but there’s a lot of active
research,’ he added.  Tshabalala-
Msimang then picked up on the theme
of foreign research exploitation before
saying that perhaps ARVs worked
better in a First World context, ‘whereas
in a South African context you must
understand it’s maybe a difficult
question – there are first and second
economies and we don’t want to
desegregate these economies – this is
why we are taking a very hard line on
the registration of all clinical trials
taking place here’.
Citing recent unnamed foreign
microbicide research that allegedly left
52 women HIV-positive, she added, ‘ if
they don’t succeed, tomorrow they’re
gone and the public sector has to take
care of the patients’.
She added with emphasis, ‘I hope
some of those who benefit from this will
also take note of our firm stand on
foreign trials’.
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